Filing Flows › Neuraxis (NRXS) › Q1 2026 › vs Q4 2025
Neuraxis (NRXS) Q1 2026 vs Q4 2025 (quarter over quarter)
Neuraxis's revenue rose $640K (+66%) from $968K in Q4 2025 to $1.6M in Q1 2026.
Neuraxis, Q1 2026: revenue $1.6M (+80% year over year), operating margin -108.3%, net loss $1.8M, operating cash flow −$1.2M. The chart draws each line against Q4 2025, the increases inside each band.
Every line
| Line | Q1 2026 | Q4 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $1.6M | $968K | $640K | +66% |
| Net loss | $1.8M | $1.7M | $53K | +3% |
| Costs & expenses | $3.4M | $2.7M | $684K | +25% |
| Operating costs | $3.3M | $2.7M | $664K | +25% |
| Interest & other, net | $21K | −$8K | $29K | — |
| Cost of revenue | $218K | $142K | $77K | +54% |
| Research & development | $100K | $146K | −$47K | -32% |
| Sales & marketing | $824K | $586K | $239K | +41% |
| General & admin | $2.2M | $1.8M | $395K | +22% |
| Operating cash sources | $1.8M | $1.7M | $53K | +3% |
| Depreciation & amortization | $16K | $24K | −$8K | -32% |
| Share-based compensation | $329K | $157K | $172K | +110% |
| Working capital & other | $186K | −$407K | $593K | — |
| Cash used in operations | $1.2M | $1.9M | −$704K | -36% |
| Net loss absorbed | $1.8M | $1.7M | $53K | +3% |
Questions
How much did Neuraxis's revenue grow quarter over quarter in Q1 2026?
Neuraxis's revenue rose $640K (+66%) from $968K in Q4 2025 to $1.6M in Q1 2026.